Does the digital rectal exam still provide value in the age of MRI?

T3 prostate cancer diagnosed by DRE is associated with more advanced disease, higher metastasis rates, and worse survival compared to mpMRI-diagnosed T3 disease. These findings suggest that T3 disease identified by DRE represents a more aggressive cancer subtype and should be considered higher-risk in clinical decision-making.